VKTX
Viking Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$25.05
−0.48%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-131.0%
Return on equity
-102.5%
Return on assets
-135.8%
Return on invested capital
0.00x
Asset turnover
-$418.4M
Cash from operations
$3.94
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026